FABIANI, IACOPO
 Distribuzione geografica
Continente #
NA - Nord America 3.083
AS - Asia 2.886
EU - Europa 2.392
SA - Sud America 600
AF - Africa 75
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.044
Nazione #
US - Stati Uniti d'America 2.897
SG - Singapore 1.090
IT - Italia 900
CN - Cina 731
RU - Federazione Russa 674
BR - Brasile 470
VN - Vietnam 357
BD - Bangladesh 233
HK - Hong Kong 149
GB - Regno Unito 132
DE - Germania 125
NL - Olanda 117
FR - Francia 105
CA - Canada 98
FI - Finlandia 88
TR - Turchia 63
IN - India 57
SE - Svezia 52
MX - Messico 51
PL - Polonia 44
IE - Irlanda 40
AR - Argentina 38
ID - Indonesia 31
ZA - Sudafrica 31
EC - Ecuador 30
IQ - Iraq 28
ES - Italia 26
PK - Pakistan 23
JP - Giappone 19
UA - Ucraina 19
CO - Colombia 18
AT - Austria 15
IL - Israele 14
MY - Malesia 14
SA - Arabia Saudita 14
VE - Venezuela 14
MA - Marocco 12
LT - Lituania 11
AE - Emirati Arabi Uniti 9
PE - Perù 9
BE - Belgio 8
PY - Paraguay 8
UZ - Uzbekistan 8
EG - Egitto 7
CL - Cile 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
JO - Giordania 6
NP - Nepal 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
GR - Grecia 5
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
GT - Guatemala 4
KR - Corea 4
LB - Libano 4
PH - Filippine 4
RO - Romania 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
MG - Madagascar 3
SI - Slovenia 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
HN - Honduras 2
KG - Kirghizistan 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
NI - Nicaragua 1
Totale 9.036
Città #
Dallas 818
Singapore 604
Ashburn 335
San Jose 324
Beijing 241
Hong Kong 145
Moscow 135
Ho Chi Minh City 126
Los Angeles 113
Milan 105
New York 99
Council Bluffs 93
Rome 70
Hanoi 69
Santa Clara 66
São Paulo 61
The Dalles 56
Munich 51
Helsinki 48
Lauterbourg 45
Hefei 43
Buffalo 40
Dublin 40
Boardman 39
Warsaw 37
Florence 35
Istanbul 35
London 35
Naples 35
Pisa 34
Denver 29
Orem 29
Lappeenranta 28
Mexico City 28
Montreal 28
Frankfurt am Main 26
Houston 25
Amsterdam 24
Brooklyn 24
Johannesburg 24
Beauharnois 23
Chicago 23
Genoa 22
Chennai 21
Rio de Janeiro 21
Haiphong 20
Phoenix 20
Lucca 19
Nuremberg 19
Atlanta 18
Seattle 18
Tokyo 18
Stockholm 17
Toronto 17
Da Nang 16
Poplar 16
Boston 14
Mumbai 13
Palermo 13
Bologna 12
Brescia 12
Cascina 12
Curitiba 12
Manchester 12
Guayaquil 11
Paris 11
San Francisco 11
Washington 11
Ankara 10
Assago 10
Belo Horizonte 10
Biên Hòa 10
Quito 10
Turin 10
Bari 9
Brasília 9
Hangzhou 9
Kuala Lumpur 9
Shenzhen 9
Tel Aviv 9
Turku 9
Charlotte 8
Chengdu 8
Dhaka 8
Guangzhou 8
Hillsboro 8
Hải Dương 8
Porto Alegre 8
Salt Lake City 8
Brussels 7
Figino 7
Goiânia 7
Lahore 7
Livorno 7
Milwaukee 7
Phủ Lý 7
Shanghai 7
Vienna 7
Casablanca 6
Changsha 6
Totale 4.956
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 609
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 380
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 313
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 288
Atrial amyloidosis: mechanisms and clinical manifestations 263
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 262
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 259
Valve disease in cardiac amyloidosis: an echocardiographic score 259
Disease features and management of cardiomyopathies in women 257
Assessing cardiac mechanics through left ventricular haemodynamic forces 245
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 242
Valvular heart disease in patients with cardiac amyloidosis 238
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 236
Role of Imaging in Cardiomyopathies 236
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 235
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 234
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions 222
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome 218
Use of new and emerging cancer drugs: what the cardiologist needs to know 217
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 214
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 211
Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook 205
Cardiovascular toxicity from therapies for light chain amyloidosis 205
The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 197
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 192
Treatment Options in AF Patients with Cancer; Focus on Catheter Ablation 186
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study 184
Advancing Cardiovascular Risk Stratification and Functional Assessment: A Narrative Review of CPET and ESE Applications 181
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 176
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 175
Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review 175
Critical Reading of cardiovascular trials with neutral or negative results 170
Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter? 162
null 159
Partial Lipodystrophy and LMNA p.R545H Variant 156
Ischemic Heart Disease in Liver Transplant Candidates With High Bleeding Risk: Any Way Out? 154
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 150
More cardiopulmonary effort testing needed in HFpEF! 144
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study 132
Safety and Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors in Active Cancer Patients with Heart Failure: Results of the Observational TOSCA Trial 120
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 116
Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis 59
PAWP vs LVEDP During Invasive Cardiopulmonary Exercise Testing: In Search of the Holy Grail of a Hemodynamic Truth in Heart Failure. 33
null 29
Exercise oscillatory ventilation in heart failure and brain–lung–heart–muscle crosstalk 3
Totale 9.101
Categoria #
all - tutte 37.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202347 0 0 0 0 4 5 4 6 18 5 5 0
2023/2024246 1 0 48 34 10 22 30 8 6 16 14 57
2024/20252.115 40 48 85 51 121 122 291 414 200 149 276 318
2025/20266.553 379 726 859 941 619 466 559 313 447 433 443 368
2026/2027140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 9.101